drugset / Trial / NCT00250250
An Open-Label, Multi-centre, Phase III Study of Local Tolerability of ZOMACTON 10MG
RandomizedSingle-groupOpen-labelTreatment
Summary
Children with growth failure due to inadequate secretion of growth hormone or growth retardation due to Turner's syndrome are individually dosed and treated for 12 weeks
Timeline
- Start
- 2005-10
- Primary completion
- 2006-03
- Completion
- 2006-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Somatropin | Protein / enzyme biologic | — | Subcutaneous |